FOXG1 variants can be associated with milder phenotypes than congenital Rett syndrome with unassisted walking and language development.

FOXG1 gene FOXG1 phenotype spectrum congenital Rett syndrome mild phenotype

Journal

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
ISSN: 1552-485X
Titre abrégé: Am J Med Genet B Neuropsychiatr Genet
Pays: United States
ID NLM: 101235742

Informations de publication

Date de publication:
08 Mar 2024
Historique:
revised: 22 01 2024
received: 07 09 2023
accepted: 30 01 2024
medline: 9 3 2024
pubmed: 9 3 2024
entrez: 8 3 2024
Statut: aheadofprint

Résumé

Since 2008, FOXG1 haploinsufficiency has been linked to a severe neurodevelopmental phenotype resembling Rett syndrome but with earlier onset. Most patients are unable to sit, walk, or speak. For years, FOXG1 sequencing was only prescribed in such severe cases, limiting insight into the full clinical spectrum associated with this gene. Next-generation sequencing (NGS) now enables unbiased diagnostics. Through the European Reference Network for Rare Malformation Syndromes, Intellectual and Other Neurodevelopmental Disorders, we gathered data from patients with heterozygous FOXG1 variants presenting a mild phenotype, defined as able to speak and walk independently. We also reviewed data from three previously reported patients meeting our criteria. We identified five new patients with pathogenic FOXG1 missense variants, primarily in the forkhead domain, showing varying nonspecific intellectual disability and developmental delay. These features are not typical of congenital Rett syndrome and were rarely associated with microcephaly and epilepsy. Our findings are consistent with a previous genotype-phenotype analysis by Mitter et al. suggesting the delineation of five different FOXG1 genotype groups. Milder phenotypes were associated with missense variants in the forkhead domain. This information may facilitate prognostic assessments in children carrying a FOXG1 variant and improve the interpretation of new variants identified with genomic sequencing.

Identifiants

pubmed: 38459409
doi: 10.1002/ajmg.b.32970
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e32970

Subventions

Organisme : Dijon University Hospital
Organisme : European Regional Development Fund
Organisme : Ricerca Corrente 5X1000

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Akol, I., Gather, F., & Vogel, T. (2022). Paving therapeutic avenues for FOXG1 syndrome: Untangling genotypes and phenotypes from a molecular perspective. International Journal of Molecular Sciences, 23(2), 954. https://doi.org/10.3390/ijms23020954
Allou, L., Lambert, L., Amsallem, D., Bieth, E., Edery, P., Destrée, A., Rivier, F., Amor, D., Thompson, E., Nicholl, J., Harbord, M., Nemos, C., Saunier, A., Moustaïne, A., Vigouroux, A., Jonveaux, P., & Philippe, C. (2012). 14q12 and severe Rett-like phenotypes: New clinical insights and physical mapping of FOXG1-regulatory elements. European Journal of Human Genetics, 20(12), 1216-1223. https://doi.org/10.1038/ejhg.2012.127
Ariani, F., Hayek, G., Rondinella, D., Artuso, R., Mencarelli, M. A., Spanhol-Rosseto, A., Pollazzon, M., Buoni, S., Spiga, O., Ricciardi, S., Meloni, I., Longo, I., Mari, F., Broccoli, V., Zappella, M., & Renieri, A. (2008). FOXG1 is responsible for the congenital variant of Rett syndrome. American Journal of Human Genetics, 83(1), 89-93. https://doi.org/10.1016/j.ajhg.2008.05.015
Bahi-Buisson, N., Nectoux, J., Girard, B., Van Esch, H., De Ravel, T., Boddaert, N., Plouin, P., Rio, M., Fichou, Y., Chelly, J., & Bienvenu, T. (2010). Revisiting the phenotype associated with FOXG1 mutations: Two novel cases of congenital Rett variant. Neurogenetics, 11(2), 241-249. https://doi.org/10.1007/s10048-009-0220-2
Cellini, E., Vignoli, A., Pisano, T., Falchi, M., Molinaro, A., Accorsi, P., Bontacchio, A., Pinelli, L., Giordano, L., Guerrini, R., & FOXG1 Syndrome Study Group. (2016). The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy. Developmental Medicine and Child Neurology, 58(1), 93-97. https://doi.org/10.1111/dmcn.12894
Collins, B. E., & Neul, J. L. (2022). Rett syndrome and MECP2 duplication syndrome: Disorders of MeCP2 dosage. Neuropsychiatric Disease and Treatment, 18, 2813-2835. https://doi.org/10.2147/NDT.S371483
De Filippis, R., Pancrazi, L., Bjørgo, K., Rosseto, A., Kleefstra, T., Grillo, E., Panighini, A., Cardarelli, F., Meloni, I., Ariani, F., Mencarelli, M. A., Hayek, J., Renieri, A., Costa, M., & Mari, F. (2012). Expanding the phenotype associated with FOXG1 mutations and in vivo FoxG1 chromatin-binding dynamics. Clinical Genetics, 82(4), 395-403. https://doi.org/10.1111/j.1399-0004.2011.01810.x
Frullanti, E., Papa, F. T., Grillo, E., Clarke, A., Ben-Zeev, B., Pineda, M., Bahi-Buisson, N., Bienvenu, T., Armstrong, J., Roche Martinez, A., Mari, F., Nissenkorn, A., Lo Rizzo, C., Veneselli, E., Russo, S., Vignoli, A., Pini, G., Djuric, M., Bisgaard, A. M., … Renieri, A. (2019). Analysis of the phenotypes in the Rett networked database. International Journal of Genomics, 2019, 6956934. https://doi.org/10.1155/2019/6956934
Hettige, N. C., & Ernst, C. (2019). FOXG1 dose in brain development. Frontiers in Pediatrics, 7, 482. https://doi.org/10.3389/fped.2019.00482
Jang, H. N., Kim, T., Jung, A. Y., Lee, B. H., Yum, M. S., & Ko, T. S. (2021). Identification of FOXG1 mutations in infantile hypotonia and postnatal microcephaly. Medicine, 100(47), e27949. https://doi.org/10.1097/MD.0000000000027949
Khan, A. A., & Kirmani, S. (2020). Mild presentation of the congenital variant Rett syndrome in a Pakistani male: Expanding the phenotype of the forkhead box protein G1 spectrum. Clinical Dysmorphology, 29(2), 111-113. https://doi.org/10.1097/MCD.0000000000000302
Kortüm, F., Das, S., Flindt, M., Morris-Rosendahl, D. J., Stefanova, I., Goldstein, A., Horn, D., Klopocki, E., Kluger, G., Martin, P., Rauch, A., Roumer, A., Saitta, S., Walsh, L. E., Wieczorek, D., Uyanik, G., Kutsche, K., & Dobyns, W. B. (2011). The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. Journal of Medical Genetics, 48(6), 396-406. https://doi.org/10.1136/jmg.2010.087528
Kumamoto, T., & Hanashima, C. (2017). Evolutionary conservation and conversion of Foxg1 function in brain development. Development, Growth & Differentiation, 59(4), 258-269. https://doi.org/10.1111/dgd.12367
Le Guen, T., Fichou, Y., Nectoux, J., Bahi-Buisson, N., Rivier, F., Boddaert, N., Diebold, B., Héron, D., Chelly, J., & Bienvenu, T. (2011). A missense mutation within the fork-head domain of the forkhead box G1 gene (FOXG1) affects its nuclear localization. Human Mutation, 32(2), E2026-E2035. https://doi.org/10.1002/humu.21422
Mencarelli, M. A., Spanhol-Rosseto, A., Artuso, R., Rondinella, D., De Filippis, R., Bahi-Buisson, N., Nectoux, J., Rubinsztajn, R., Bienvenu, T., Moncla, A., Chabrol, B., Villard, L., Krumina, Z., Armstrong, J., Roche, A., Pineda, M., Gak, E., Mari, F., Ariani, F., & Renieri, A. (2010). Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. Journal of Medical Genetics, 47(1), 49-53. https://doi.org/10.1136/jmg.2009.067884
Méneret, A., Mignot, C., An, I., Habert, M. O., Jacquette, A., Vidailhet, M., Bienvenu, T., & Roze, E. (2012). Generalized dystonia, athetosis, and parkinsonism associated with FOXG1 mutation. Movement Disorders: Official Journal of the Movement Disorder Society, 27(1), 160-161. https://doi.org/10.1002/mds.23956
Mitter, D., Pringsheim, M., Kaulisch, M., Plümacher, K. S., Schröder, S., Warthemann, R., Abou Jamra, R., Baethmann, M., Bast, T., Büttel, H. M., Cohen, J. S., Conover, E., Courage, C., Eger, A., Fatemi, A., Grebe, T. A., Hauser, N. S., Heinritz, W., Helbig, K. L., … Brockmann, K. (2018). FOXG1 syndrome: Genotype-phenotype association in 83 patients with FOXG1 variants. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 20(1), 98-108. https://doi.org/10.1038/gim.2017.75
Philippe, C., Amsallem, D., Francannet, C., Lambert, L., Saunier, A., Verneau, F., & Jonveaux, P. (2010). Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. Journal of Medical Genetics, 47(1), 59-65. https://doi.org/10.1136/jmg.2009.067355
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., & ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 17(5), 405-424. https://doi.org/10.1038/gim.2015.30
Terrone, G., Bienvenu, T., Germanaud, D., Barthez-Carpentier, M. A., Diebold, B., Delanoe, C., Passemard, S., & Auvin, S. (2014). A case of Lennox-Gastaut syndrome in a patient with FOXG1-related disorder. Epilepsia, 55(11), e116-e119. https://doi.org/10.1111/epi.12800
Toresson, H., Martinez-Barbera, J. P., Bardsley, A., Caubit, X., & Krauss, S. (1998). Conservation of BF-1 expression in amphioxus and zebrafish suggests evolutionary ancestry of anterior cell types that contribute to the vertebrate telencephalon. Development Genes and Evolution, 208(8), 431-439. https://doi.org/10.1007/s004270050200
Van der Aa, N., Van den Bergh, M., Ponomarenko, N., Verstraete, L., Ceulemans, B., & Storm, K. (2011). Analysis of FOXG1 is highly recommended in male and female patients with Rett syndrome. Molecular Syndromology, 1(6), 290-293. https://doi.org/10.1159/000330755
Vegas, N., Cavallin, M., Maillard, C., Boddaert, N., Toulouse, J., Schaefer, E., Lerman-Sagie, T., Lev, D., Magalie, B., Moutton, S., Haan, E., Isidor, B., Heron, D., Milh, M., Rondeau, S., Michot, C., Valence, S., Wagner, S., Hully, M., … Bahi-Buisson, N. (2018). Delineating FOXG1 syndrome: From congenital microcephaly to hyperkinetic encephalopathy. Neurology. Genetics, 4(6), e281. https://doi.org/10.1212/NXG.0000000000000281
Wong, L. C., Singh, S., Wang, H. P., Hsu, C. J., Hu, S. C., & Lee, W. T. (2019). FOXG1-related syndrome: From clinical to molecular genetics and pathogenic mechanisms. International Journal of Molecular Sciences, 20(17), 4176. https://doi.org/10.3390/ijms20174176
Wong, L. C., Wu, Y. T., Hsu, C. J., Weng, W. C., Tsai, W. C., & Lee, W. T. (2019). Cognition and evolution of movement disorders of FOXG1-related syndrome. Frontiers in Neurology, 10, 641. https://doi.org/10.3389/fneur.2019.00641
Xuan, S., Baptista, C. A., Balas, G., Tao, W., Soares, V. C., & Lai, E. (1995). Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron, 14(6), 1141-1152. https://doi.org/10.1016/0896-6273(95)90262-7

Auteurs

Benoit Mazel (B)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Génétique, FHU TRANSLAD - CHU Dijon Bourgogne, Dijon, France.
Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.

Julian Delanne (J)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Génétique, FHU TRANSLAD - CHU Dijon Bourgogne, Dijon, France.
Centre de référence Déficiences Intellectuelles de Causes Rares, CHU Dijon Bourgogne, Dijon, France.

Aurore Garde (A)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Génétique, FHU TRANSLAD - CHU Dijon Bourgogne, Dijon, France.
Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.

Caroline Racine (C)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Génétique, FHU TRANSLAD - CHU Dijon Bourgogne, Dijon, France.
Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.

Ange-Line Bruel (AL)

Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.
Laboratoire de Génomique Médicale, Unité Fonctionnelle Innovation en diagnostic génomique, Unité fonctionnelle innovation en diagnostic génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.

Yannis Duffourd (Y)

Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.
Laboratoire de Génomique Médicale, Unité Fonctionnelle Innovation en diagnostic génomique, Unité fonctionnelle innovation en diagnostic génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.

Diego Lopergolo (D)

Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Stella Maris Foudation, Pisa, Italy.

Filippo Maria Santorelli (FM)

Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Stella Maris Foudation, Pisa, Italy.

Viviana Marchi (V)

Department of Developmental Neuroscience, Stella Maris Scientific Institute, IRCCS Fondazione Stella Maris Foundation, Pisa, Italy.

Anna Maria Pinto (AM)

Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Maria Antonietta Mencarelli (MA)

Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Roberto Canitano (R)

Division of Child and Adolescent Neuropsychiatry, University Hospital of Siena, Siena, Italy.

Floriana Valentino (F)

Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Siena, Italy.

Filomena Tiziana Papa (FT)

Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Siena, Italy.

Chiara Fallerini (C)

Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Siena, Italy.
Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, Siena, Italy.

Francesca Mari (F)

Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Siena, Italy.

Alessandra Renieri (A)

Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Medical Genetics Unit, University of Siena, Policlinico Le Scotte, Siena, Italy.
Department of Medical Biotechnologies, Med Biotech Hub and Competence Center, University of Siena, Siena, Italy.

Arnold Munnich (A)

Service de Génétique Médicale et Clinique, Hôpital Necker Enfants Malades, Paris, France.

Tanguy Niclass (T)

Service de Génétique Clinique, CHU de Poitiers, Poitiers, France.

Gwenaël Le Guyader (G)

Service de Génétique Clinique, CHU de Poitiers, Poitiers, France.

Christel Thauvin-Robinet (C)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Génétique, FHU TRANSLAD - CHU Dijon Bourgogne, Dijon, France.
Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.
Centre de référence Déficiences Intellectuelles de Causes Rares, CHU Dijon Bourgogne, Dijon, France.
Laboratoire de Génomique Médicale, Unité Fonctionnelle Innovation en diagnostic génomique, Unité fonctionnelle innovation en diagnostic génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.

Christophe Philippe (C)

Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.
Laboratoire de Génomique Médicale, Unité Fonctionnelle Innovation en diagnostic génomique, Unité fonctionnelle innovation en diagnostic génomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.

Laurence Faivre (L)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Génétique, FHU TRANSLAD - CHU Dijon Bourgogne, Dijon, France.
Inserm UMR1231 GAD, Génétique des Anomalies du Développement, Université de Bourgogne, Dijon, France.

Classifications MeSH